| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Virology, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Texas Medical Center, Houston, Texas 77025
Sera of C3H/Z/Dm mice bearing spontaneous mammary tumors, sera of apparently normal C3H/Z/Dm mice at different ages, and a serum of an A/Dm mouse with spontaneous breast cancer were tested by the indirect immunoperoxidase method against cells of C3H/HeJ spontaneous mammary tumor line constantly producing type B or mouse mammary tumor virus particles. The sera were also tested against cells of C3H/He/TEX spontaneous mammary tumor line producing no virus particles. Sera of C3H/Z/Dm and A/Dm tumor-bearing mice and serum of an apparently normal C3H/Z/Dm mouse gave peroxidase labeling of immature and mature type B or mouse mammary tumor virus particles and also of budding type B particles. No peroxidase labeling of intracytoplasmic type A virus particles was observed. In addition, peroxidase labeling of certain parts (presumably, antigen formation sites) of plasma membrane of the C3H/HeJ mammary tumor cells was seen. Absorption of the positive mouse sera with guinea pig kidney cells, C3H/Z/Dm mouse embryo cells, C3H/Z/Dm spontaneous mammary tumor cells, or with mammary tumor virus from milk of C3H/Z/Dm mice demonstrated that the immunoperoxidase reaction was due to specific antivirus antibodies. Positive sera failed to react with cells of the C3H/He/TEX mammary tumor line producing no virus particles.
A number of sera from patients with breast cancer and from their relatives were also tested by immunoperoxidase reaction against cells of the C3H/HeJ spontaneous mouse mammary tumor line. As in the case of positive mouse sera, some human sera gave peroxidase labeling of type B and budding virus particles. Absorption with suitable material (guinea pig kidney, sheep red blood cells, whole human embryo cells, breast tumor tissue homogenates, and a mouse mammary tumor virus preparation) demonstrated that the antibodies in human sera are specifically directed against mouse mammary tumor virus particles.
1 This study was supported in part by Contract PH43-NCI-E-65-604 within the Special Virus Cancer Program and in part by Grants CA-05831 and RR-05511 of the National Cancer Institute, NIH, USPHS.
2 To whom requests for reprints should be addressed.
Received 5/14/73. Accepted 6/29/73.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |